High Extratumoral Mast Cell Counts Are Associated with a Higher Risk of Adverse Prostate Cancer Outcomes.

Heidi Hempel SullivanChristopher M Heaphy Ibrahim KulacNathan CukaJiayun LuJohn R BarberAngelo M DeMarzoTamara L LotanCorrine E JoshuKaren S Sfanos

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)

Higher numbers of benign tissue mast cells are associated with a higher risk of adverse outcomes after radical prostatectomy, including metastatic prostate cancer.

Keyphrases

radical prostatectomy
prostate cancer
small cell lung cancer
emergency department
type diabetes
adverse drug
metabolic syndrome
weight loss